| P2093 | author name string | Giulia Veronesi | |
| | John M Varlotto | |
| P2860 | cites work | Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. | Q52586557 |
| | Robotic resection of Stage III lung cancer: an international retrospective study. | Q52714831 |
| | Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis. | Q53239733 |
| | Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial | Q56768701 |
| | Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis | Q59587327 |
| | Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study | Q73181614 |
| | Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer | Q29620902 |
| | Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer | Q29620913 |
| | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| | Prophylactic cranial irradiation in extensive small-cell lung cancer | Q34005742 |
| | Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto | Q35568485 |
| | Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer | Q38975751 |
| | Video-assisted thoracoscopic surgery lobectomy at 20 years: a consensus statement | Q39331750 |
| | Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial | Q40163779 |
| | Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. | Q40408396 |
| | Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer | Q47834638 |
| | Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer | Q47887111 |
| | Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial | Q47938054 |
| | Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery | Q48961059 |
| | The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study. | Q50069245 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 233 | |
| P577 | publication date | 2018-06-18 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Editorial: Controversies in the Local Management of Lung Cancer. | |
| P478 | volume | 8 | |